Home › Research › Topics › assessment
assessment
849 studies tagged assessment, dated 1982-05-01 to 2026-09-16. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
- Feasibility of remote self-administered cognitive assessment in an Alzheimer's disease treatment clinic 2026-09-16
- Structural brain imaging for newly diagnosed cognitive impairment by Medicare coverage type 2026-09-15
- Detection and Continuous Monitoring of Memory Dysfunction in Mild Cognitive Impairment and Healthy Aging Through Adaptive Computational Phenotyping 2026-09-12
Studies
849 studies carry this tag.
Date range
1982 to 2026
Top journals
- Neurology 63
- Journal of Alzheimer's disease : JAD 31
- Archives of neurology 30
- Alzheimer s & Dementia 25
- Alzheimer's & dementia : the journal of the Alzheimer's Association 21
316 journals in all.
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
The five-predictor combination strongly predicted conversion to AD and was markedly superior to combining age and MMSE.
-
Current classifications of MCI have variable outcomes in population-based samples.
-
46/100
Two-thirds of MCI-multidomains, but only half of MCI-amnestic progress to AD.
-
The MMSE is the most widely used cognitive test but its accuracy and clinical utility in diagnosing cognitive disorders is not fully known.
-
The Mini-Mental State Examination (MMSE) is the most widely used instrument for the screening of cognitive impairment worldwide, but its ability to produce valid estimates of dementia in populations of low socioeconomic status and minimal literacy skills has not been adequately established.
-
The Montreal Cognitive Assessment (MoCA) is a brief cognitive screening tool with high sensitivity for screening patients with mild cognitive impairment (MCI).
-
The Mini-Mental State Examination (MMSE) has contributed to detecting cognitive impairment, yet few studies have evaluated its accuracy when used by general practitioners (GP) in an actual public-health setting.
-
Future research should address the question of whether performance-based functional measures, as well as simple queries regarding whether functional activities take longer than usual to complete, may improve the prediction of future cognitive decline and disease progression among those individuals in whom MCI represents impending dementia.
-
Men and women have different risk profiles for both MCI and progression to dementia.
-
50/100
Emotion recognition progresses from a deficit in low-intensity fearful facial recognition in a-MCI phase to a deficit in all intensities and emotions in mild AD.
-
Impaired memory and language were useful predictors of transition to AD.
-
Multiple pathogenic factors may contribute to the pathophysiology of Alzheimer's disease (AD).
-
The ACR is approximately 5-10% and most people with MCI will not progress to dementia even after 10 years of follow-up.
-
Dementia is an important and increasingly recognized problem in Parkinson's disease (PD).
-
Mild cognitive impairment (MCI) refers to the transitional state between the cognitive changes of normal aging and very early dementia.
-
As different signature changes associated with particular stages of disease burden are identified and validated, we anticipate expanded application of qEEG as a reliable and sensitive biomarker(s) of MCI and early Alzheimer's disease.
-
Alzheimer's disease (AD), the most common neurodegenerative disorder of the elderly, ranks third in health care cost after heart disease and cancer.
-
50/100
Abnormalities of the P600 or N400 in mild cognitive impairment are associated with an increased risk of subsequent conversion to Alzheimer disease (AD).
-
63/100
From a longitudinal study of normal (Clinical Dementia Rating [CDR] = 0; n = 77) and mildly impaired (CDR = 0.5; n = 167) participants with 5 or more annual clinical assessments, baseline level of cognitive impairment in daily life was graded using CDR sum of boxes (CDR-SB) and level of cognitive performance impairment was graded using neuropsychological test scores.
-
In subjects with aMCI poor global cognitive performance at baseline, the worsening on executive functions and on functional status but not the worsening on memory functions are independently associated with the conversion to dementia of Alzheimer type at 1 year, follow-up.
-
A history of hypertension is related to a higher risk of MCI.
-
Rates of atrophy accelerate as individuals progress from amnestic mild cognitive impairment (aMCI) to typical late onset Alzheimer disease (AD).
-
MCI occurs often in this elderly Italian cohort and is associated with greater risk of AD, but only when the impairment involves the memory domain.
-
62/100
No significant differences emerged in the probability of conversion from MCI to AD or dementia between the treated groups and the placebo groups.
-
Increasing evidence supports a role for oxidative damage in the pathogenesis of Alzheimer's disease (AD).
-
Spatial patterns of brain atrophy in mild cognitive impairment (MCI) and Alzheimer's disease (AD) were measured via methods of computational neuroanatomy.
-
Recent randomized control trials and meta-analyses of experimental studies indicate positive effects of non-pharmacological cognitive training on the cognitive function of healthy older adults.
-
Level of conscientiousness is a risk factor for Alzheimer disease.
-
51/100
The regions of loss observed in subjects with amnestic mild cognitive impairment (aMCI) who progressed to Alzheimer disease (AD) within 18 months of the MRI are typical of subjects with AD.
-
At baseline and at follow-up MCI-AD showed higher levels P-tau(231), T-tau, IP, P-tau(231)/Abeta(42/40) and T-tau/Abeta(42/40) ratios and lower Abeta(42)/Abeta(40) than MCI-MCI or NL-NL.
-
MCI is frequent in elderly patients of GPs.
-
The navigation disability in Alzheimer disease and mild cognitive impairment (MCI) involves a selective impairment of spatial cognition and is associated with atrophy of the right-lateralized navigation network.
-
These findings suggest that neuropsychiatric symptoms in MCI are a predictor of progression to AD.
-
MCI is a nosological entity proposed as an intermediate state between normal aging and dementia.
-
Free radical-mediated oxidative damage is thought to play a role in the pathogenesis of Alzheimer disease.
-
Our purpose was to characterize a state of mild cognitive impairment (MCI) in Parkinson's disease (PD) (PD-MCI) that would be analogous to the MCI that is posited as a precursor of Alzheimer's disease (AD).
-
Medial temporal lobe atrophy seems to be a more important predictor of cognition than small-vessel disease in MCI.
-
The regression models showed that older age, education levels, language spoken at home and in country of birth, socioeconomic status (SES), occupation, sex, and presence of a mood disorder made significant and unique contributions to performance on the MMSE.
-
Tests of both episodic memory and executive function are predictors of time to progression from mild impairment to a clinical diagnosis of Alzheimer disease.
-
57/100
We conclude that conversion rate from MCI to DSM-IIIR dementia was 21.9% over a period of 3 years.
-
The predictive validity of mild cognitive impairment (MCI) for identifying future Alzheimer disease (AD) cases is improved in the presence of anxiety symptoms.
-
The MoCA is a useful brief screening tool for the detection of mild dementia or MCI in subjects scoring over 25 points on the MMSE.
-
Structural brain changes in anatomic areas involved in higher cognitive processes precede clinical signs and symptoms in longitudinally followed normal subjects destined to develop mild cognitive impairment.
-
Diabetes is related to a higher risk of amnestic MCI in a population with a high prevalence of this disorder.
-
64/100
Hippocampal and entorhinal cortex volumes were each largest in controls, intermediate in MCI nonconverters, and smallest in MCI converters to AD (37 of 139 patients converted to AD).
-
58/100
The authors used mixed-effects growth models to examine longitudinal change in neuropsychological performance over a 4-year period among 197 individuals who were either normal or had mild cognitive impairment (MCI) at baseline.
-
Patients with Alzheimer's disease (AD) frequently have difficulties with spatial orientation in their day-to-day life.
-
69/100
Progression from amnestic mild cognitive impairment to Alzheimer disease in this cohort was best determined by combining four common, easily administered, cognitive measures.
-
There were significant ethnic differences in mean MMSE scores among Chinese (26.2), Indians (25.0), and Malays (23.6), but only in noneducated subjects.
-
Mild cognitive impairment refers to the transitional state between the cognitive changes of normal aging and the fully developed clinical features of dementia.
From across this tag
9 of the 848 studies in this tag, picked by a fixed rule (a hash of each study's address), not by score or date; each page of this list shows a different 9. The same 9 appear here every time.
- The diagnostic accuracy of the Mini-Cog screening tool for the detection of cognitive impairment—A systematic review and meta-analysis
- Electroencephalogram and Event-Related Potential in Mild Cognitive Impairment: Recent Developments in Signal Processing, Machine Learning, and Deep Learning
- The Goteborg MCI study: mild cognitive impairment is a heterogeneous condition
- Computerized cognitive training for memory functions in mild cognitive impairment or dementia: a systematic review and meta-analysis
- Mapping scores onto stages: mini-mental state examination and clinical dementia rating
- Characterizing Neighborhood Vulnerabilities in Mild Cognitive Impairment using the Environmental Justice Index
- The association of neuropsychiatric symptoms in MCI with incident dementia and Alzheimer disease
- Effects of Normative Adjustments to the Montreal Cognitive Assessment
- Feasibility of remote self-administered cognitive assessment in an Alzheimer's disease treatment clinic